Study of the Contribution of Osteopathic Treatment to Classic Medical Management in Patients With Chronic Low Back Pain
1 other identifier
interventional
199
1 country
1
Brief Summary
The management of chronic low back pain is now part of a multi-disciplinary set of proposals with the aim of adapting for each patient orientations of both medicated and non-medicated care. Very classically, analgesic treatment of stage I or II is of use, reinforced by the occasional use of NSAIDs in the absence of contraindication. In this medical attempt of the control of the pain associates a physical care (supervised exercises, physiotherapy care), cognitive and behavioral therapy, multidisciplinary care. Osteopathic treatment is a specific manual diagnostic and therapeutic procedure. This study aims to evaluate the relevance of providing osteopathic treatment in combination with classical medical treatment in the management of patients with chronic non-specific low back pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 7, 2019
CompletedFirst Posted
Study publicly available on registry
February 11, 2019
CompletedStudy Start
First participant enrolled
October 2, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2028
March 6, 2026
March 1, 2026
8.7 years
February 7, 2019
March 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain VAS Visual Analog Scale
The primary outcome is the change in the VAS score on a 0-100 mm scale between Day 0 (before the placement of any osteopathic manipulations for Arm 3 ( or sham osteopathic treatment for Arm 2) and J90 ( after the last osteopathic treatment session for Arm 3 (sham osteopathic treatment for Arm 2)).
Change from baseline to 3 months
Secondary Outcomes (7)
Pain VAS , level improvement
Baseline, Day 15, Month 1, Month 2, Month 3, Month 6
Relief Numerical scale
Day 15, Month 1, Month 2, Month 3, Month 6
Drug consumption
Baseline, Day 15, Month 1, Month 2, Month 3, Month 6
Hand-Ground Distance and Schöber test
Baseline, Day 15, Month 1, Month 2, Month 3, Month 6
Oswestry score
Baseline, Day 15, Month 1, Month 2, Month 3, Month 6
- +2 more secondary outcomes
Study Arms (3)
1-Current practice Medication treatment
OTHERMedication treatment according to current practice.
2- Sham osteopathic treatment
SHAM COMPARATORMedication treatment according to current practice + sham osteopathic treatment.
3- Osteopathic treatment
EXPERIMENTALMedication treatment according to current practice + osteopathic treatment.
Interventions
5 osteopathic treatment sessions lasting 20 to 40 minutes. Each session include diagnosis according to the specific methodology "geometric model of osteopathy" and treatment of necessary elements and a control of osteopathic treatment at the end of the session.
5 sham osteopathic treatment sessions lasting 20 to 40 minutes. Each session include diagnosis according to the specific methodology "geometric model of osteopathy" and only contacts for no intent to treat. At the end of the session a control of the sham osteopathic treatment is performed.
Analgesic medication of level 1 or a combination of level 1 and 2. Acetaminophen 1 g x 3 / day Ibuprofen 400mg x 3 / day
Eligibility Criteria
You may qualify if:
- Patient with chronic non-specific low back pain: degenerative lumbalgia and low back pain unrelated to anatomical lesions that have been evolving for more than 3 months.
- Patient affiliated with a social security scheme or equivalent
- Patient having signed the study informed consent form.
You may not qualify if:
- Patient with specific low back pain: patient with one of the following pathologies: degenerative neurological pathology; infectious pathology; fracture vertebral lesion less than 1 year; vertebral osteosynthesis material or canal narrowing.
- Patient following a treatment of the Morphinic or Neuroleptic type.
- Pregnant, breastfeeding or parturient woman
- Patient participating in another clinical study
- Protected patient: Major under some form of guardianship ; Hospitalized without consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Clinique Pasteurlead
Study Sites (1)
Clinique Pasteur
Toulouse, 31076, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Barthélémy De Truchis de Varennes, MD
Clinique Pasteur
- STUDY CHAIR
François Djabaku, DO
- STUDY CHAIR
Barthélémy De Truchis de Varennes, MD
Clinique Pasteur
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 7, 2019
First Posted
February 11, 2019
Study Start
October 2, 2019
Primary Completion (Estimated)
June 1, 2028
Study Completion (Estimated)
September 1, 2028
Last Updated
March 6, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share